Shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $1.20 and traded as high as $1.4806. Oxbridge Re shares last traded at $1.39, with a volume of 17,987 shares.
Analyst Upgrades and Downgrades
OXBR has been the subject of a number of research reports. Maxim Group cut their price objective on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a research note on Tuesday, June 16th. Weiss Ratings upgraded shares of Oxbridge Re from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, July 28th. Finally, Zacks Research raised shares of Oxbridge Re to a “hold” rating in a research note on Wednesday, June 17th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $3.00.
Check Out Our Latest Report on Oxbridge Re
Oxbridge Re Stock Performance
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the company. Virtu Financial LLC bought a new stake in Oxbridge Re during the 3rd quarter valued at $32,000. International Assets Investment Management LLC bought a new stake in Oxbridge Re in the 4th quarter worth $39,000. Finally, J.W. Cole Advisors Inc. grew its holdings in Oxbridge Re by 106.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock worth $90,000 after acquiring an additional 35,000 shares during the last quarter. Institutional investors own 5.64% of the company’s stock.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Featured Stories
- Five stocks we like better than Oxbridge Re
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
